Compile Data Set for Download or QSAR

Found 1592 hits of ph data with Target = 'Tyrosine-protein kinase BTK'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263548 (2-{5-amino-1-[4-(3-cyano- phenoxy)-2-methyl-phenyl...) Show SMILES Cc1cc(Oc2cccc(c2)C#N)ccc1-n1ncc(C(=O)c2cc3cc(ccc3[nH]2)C(=O)NCCN)c1N Show InChI InChI=1S/C29H25N7O3/c1-17-11-22(39-21-4-2-3-18(12-21)15-31)6-8-26(17)36-28(32)23(16-34-36)27(37)25-14-20-13-19(5-7-24(20)35-25)29(38)33-10-9-30/h2-8,11-14,16,35H,9-10,30,32H2,1H3,(H,33,38)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263549 (3-(4-{5-amino-4-[5- (morpholine-4-carbonyl)-1h- in...) Show SMILES NC(=O)c1cccc(Oc2ccc(c(Cl)c2)-n2ncc(C(=O)c3cc4cc(ccc4[nH]3)C(=O)N3CCOCC3)c2N)c1 Show InChI InChI=1S/C30H25ClN6O5/c31-23-15-21(42-20-3-1-2-17(13-20)29(33)39)5-7-26(23)37-28(32)22(16-34-37)27(38)25-14-19-12-18(4-6-24(19)35-25)30(40)36-8-10-41-11-9-36/h1-7,12-16,35H,8-11,32H2,(H2,33,39)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	50	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263550 (2-{5-amino-1-[4-(3-cyano- phenoxy)-2-methyl-phenyl...) Show SMILES COC(=O)c1ccc2[nH]c(nc2c1)C(=O)c1cnn(c1N)-c1ccc(Oc2cccc(c2)C#N)cc1C Show InChI InChI=1S/C27H20N6O4/c1-15-10-19(37-18-5-3-4-16(11-18)13-28)7-9-23(15)33-25(29)20(14-30-33)24(34)26-31-21-8-6-17(27(35)36-2)12-22(21)32-26/h3-12,14H,29H2,1-2H3,(H,31,32)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	150	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263551 (3-(4-{5-amino-4-[5- (morpholine-4-carbonyl)-1h- be...) Show SMILES Cc1cc(Oc2cccc(c2)C#N)ccc1-n1ncc(C(=O)c2nc3cc(ccc3[nH]2)C(=O)N2CCOCC2)c1N Show InChI InChI=1S/C30H25N7O4/c1-18-13-22(41-21-4-2-3-19(14-21)16-31)6-8-26(18)37-28(32)23(17-33-37)27(38)29-34-24-7-5-20(15-25(24)35-29)30(39)36-9-11-40-12-10-36/h2-8,13-15,17H,9-12,32H2,1H3,(H,34,35)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	24	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263552 (2-{5-amino-1-[4-(3-cyano- phenoxy)-2-methyl-phenyl...) Show SMILES COCCNC(=O)c1ccc2[nH]c(nc2c1)C(=O)c1cnn(c1N)-c1ccc(Oc2cccc(c2)C#N)cc1C Show InChI InChI=1S/C29H25N7O4/c1-17-12-21(40-20-5-3-4-18(13-20)15-30)7-9-25(17)36-27(31)22(16-33-36)26(37)28-34-23-8-6-19(14-24(23)35-28)29(38)32-10-11-39-2/h3-9,12-14,16H,10-11,31H2,1-2H3,(H,32,38)(H,34,35)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	23	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263553 (2-{5-amino-1-[2-chloro-4-(3- cyano-phenoxy)-phenyl...) Show SMILES Nc1c(cnn1-c1ccc(Oc2cccc(c2)C#N)cc1Cl)C(=O)c1cc2cc(ccc2[nH]1)C(=O)NC#N Show InChI InChI=1S/C27H16ClN7O3/c28-21-11-19(38-18-3-1-2-15(8-18)12-29)5-7-24(21)35-26(31)20(13-33-35)25(36)23-10-17-9-16(27(37)32-14-30)4-6-22(17)34-23/h1-11,13,34H,31H2,(H,32,37)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	52	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263554 (2-{5-amino-1-[4-(3-cyano- phenoxy)-2-methyl-phenyl...) Show SMILES Cc1cc(Oc2cccc(c2)C#N)ccc1-n1ncc(C(=O)c2nc3cc(ccc3[nH]2)C(O)=O)c1N Show InChI InChI=1S/C26H18N6O4/c1-14-9-18(36-17-4-2-3-15(10-17)12-27)6-8-22(14)32-24(28)19(13-29-32)23(33)25-30-20-7-5-16(26(34)35)11-21(20)31-25/h2-11,13H,28H2,1H3,(H,30,31)(H,34,35)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	130	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263555 (2-(4-{5-amino-4-[5- (morpholine-4-carbonyl)-1h- in...) Show SMILES Cc1cc(Oc2ccccc2C#N)ccc1-n1ncc(C(=O)c2cc3cc(ccc3[nH]2)C(=O)N2CCOCC2)c1N Show InChI InChI=1S/C31H26N6O4/c1-19-14-23(41-28-5-3-2-4-21(28)17-32)7-9-27(19)37-30(33)24(18-34-37)29(38)26-16-22-15-20(6-8-25(22)35-26)31(39)36-10-12-40-13-11-36/h2-9,14-16,18,35H,10-13,33H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.30	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263556 (3-(4-{5-amino-4-[5-(4-methyl- piperazine-1-carbony...) Show SMILES CN1CCN(CC1)C(=O)c1ccc2[nH]c(cc2c1)C(=O)c1cnn(c1N)-c1ccc(Oc2cccc(c2)C#N)cc1Cl Show InChI InChI=1S/C31H26ClN7O3/c1-37-9-11-38(12-10-37)31(41)20-5-7-26-21(14-20)15-27(36-26)29(40)24-18-35-39(30(24)34)28-8-6-23(16-25(28)32)42-22-4-2-3-19(13-22)17-33/h2-8,13-16,18,36H,9-12,34H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263557 (US9556150, i-45 | cyclopropanesulfonic acid (2-{5-...) Show SMILES Nc1c(cnn1-c1ccc(Oc2cccc(c2)C#N)cc1Cl)C(=O)c1cc2cc(ccc2[nH]1)C(=O)NS(=O)(=O)C1CC1 Show InChI InChI=1S/C29H21ClN6O5S/c30-23-13-20(41-19-3-1-2-16(10-19)14-31)5-9-26(23)36-28(32)22(15-33-36)27(37)25-12-18-11-17(4-8-24(18)34-25)29(38)35-42(39,40)21-6-7-21/h1-5,8-13,15,21,34H,6-7,32H2,(H,35,38)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.70	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263558 (2-(4-{5-amino-4-[5-(4-methyl- piperazine-1-carbony...) Show SMILES CN(C)C(=O)c1ccccc1Oc1ccc(c(Cl)c1)-n1ncc(C(=O)c2cc3cc(ccc3[nH]2)C(=O)N2CCN(C)CC2)c1N Show InChI InChI=1S/C33H32ClN7O4/c1-38(2)33(44)23-6-4-5-7-29(23)45-22-9-11-28(25(34)18-22)41-31(35)24(19-36-41)30(42)27-17-21-16-20(8-10-26(21)37-27)32(43)40-14-12-39(3)13-15-40/h4-11,16-19,37H,12-15,35H2,1-3H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.20	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263559 (3-(4-{5-amino-4-[5-(4-methyl- piperazine-1-carbony...) Show SMILES CN(C)C(=O)c1cccc(Oc2ccc(c(Cl)c2)-n2ncc(C(=O)c3cc4cc(ccc4[nH]3)C(=O)N3CCN(C)CC3)c2N)c1 Show InChI InChI=1S/C33H32ClN7O4/c1-38(2)32(43)20-5-4-6-23(16-20)45-24-8-10-29(26(34)18-24)41-31(35)25(19-36-41)30(42)28-17-22-15-21(7-9-27(22)37-28)33(44)40-13-11-39(3)12-14-40/h4-10,15-19,37H,11-14,35H2,1-3H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	32	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263560 (2-{5-amino-1-[2-chloro-4-(3- cyano-2-fluoro-phenox...) Show SMILES Nc1c(cnn1-c1ccc(Oc2cccc(C#N)c2F)cc1Cl)C(=O)c1cc2cc(ccc2[nH]1)C(O)=O Show InChI InChI=1S/C26H15ClFN5O4/c27-18-10-16(37-22-3-1-2-14(11-29)23(22)28)5-7-21(18)33-25(30)17(12-31-33)24(34)20-9-15-8-13(26(35)36)4-6-19(15)32-20/h1-10,12,32H,30H2,(H,35,36)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.20	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263561 (2-{5-amino-1-[2-chloro-4-(2- dimethylcarbamoyl-phe...) Show SMILES CN(C)CCNC(=O)c1ccc2[nH]c(cc2c1)C(=O)c1cnn(c1N)-c1ccc(Oc2ccccc2C(=O)N(C)C)cc1Cl Show InChI InChI=1S/C32H32ClN7O4/c1-38(2)14-13-35-31(42)19-9-11-25-20(15-19)16-26(37-25)29(41)23-18-36-40(30(23)34)27-12-10-21(17-24(27)33)44-28-8-6-5-7-22(28)32(43)39(3)4/h5-12,15-18,37H,13-14,34H2,1-4H3,(H,35,42)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.40	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263562 (2-{5-amino-1-[2-chloro-4-(2- dimethylcarbamoyl-phe...) Show SMILES CN(C)C1CCN(C1)C(=O)c1ccc2[nH]c(cc2c1)C(=O)c1cnn(c1N)-c1ccc(Oc2ccccc2C(=O)N(C)C)cc1Cl Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.5	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263563 (2-(4-{5-amino-4-[5-(piperazine- 1-carbonyl)-1h-ind...) Show SMILES CN(C)C(=O)c1ccccc1Oc1ccc(c(Cl)c1)-n1ncc(C(=O)c2cc3cc(ccc3[nH]2)C(=O)N2CCNCC2)c1N Show InChI InChI=1S/C32H30ClN7O4/c1-38(2)32(43)22-5-3-4-6-28(22)44-21-8-10-27(24(33)17-21)40-30(34)23(18-36-40)29(41)26-16-20-15-19(7-9-25(20)37-26)31(42)39-13-11-35-12-14-39/h3-10,15-18,35,37H,11-14,34H2,1-2H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.10	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263564 (US9556150, i-52 | [1-(2-{5-amino-1-[2-chloro-4- (2...) Show SMILES CN(C)C(=O)c1ccccc1Oc1ccc(c(Cl)c1)-n1ncc(C(=O)c2cc3cc(ccc3[nH]2)C(=O)N2CCC(C2)N(C)C(=O)OC(C)(C)C)c1N Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	17	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263565 (2-(4-{5-amino-4-[5-(3- dimethylamino-pyrrolidine-1...) Show SMILES CNC1CCN(C1)C(=O)c1ccc2[nH]c(cc2c1)C(=O)c1cnn(c1N)-c1ccc(Oc2ccccc2C(=O)N(C)C)cc1Cl Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.70	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263566 (2-{5-amino-1-[2-chloro-4-(2- dimethylcarbamoyl-phe...) Show SMILES CN(C)C(=O)c1ccccc1Oc1ccc(c(Cl)c1)-n1ncc(C(=O)c2cc3cc(ccc3[nH]2)C(=O)NC2CCN(C)C2)c1N Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.90	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263567 (US9556150, i-55 | {2-[(2-{5-amino-1-[2-chloro-4- (...) Show SMILES CN(C)C(=O)c1ccccc1Oc1ccc(c(Cl)c1)-n1ncc(C(=O)c2cc3cc(ccc3[nH]2)C(=O)NCCN(C)C(=O)OC(C)(C)C)c1N Show InChI InChI=1S/C36H38ClN7O6/c1-36(2,3)50-35(48)43(6)16-15-39-33(46)21-11-13-27-22(17-21)18-28(41-27)31(45)25-20-40-44(32(25)38)29-14-12-23(19-26(29)37)49-30-10-8-7-9-24(30)34(47)42(4)5/h7-14,17-20,41H,15-16,38H2,1-6H3,(H,39,46)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.10	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263568 (2-{5-amino-1-[2-chloro-4-(2- dimethylcarbamoyl-phe...) Show SMILES CNCCNC(=O)c1ccc2[nH]c(cc2c1)C(=O)c1cnn(c1N)-c1ccc(Oc2ccccc2C(=O)N(C)C)cc1Cl Show InChI InChI=1S/C31H30ClN7O4/c1-34-12-13-35-30(41)18-8-10-24-19(14-18)15-25(37-24)28(40)22-17-36-39(29(22)33)26-11-9-20(16-23(26)32)43-27-7-5-4-6-21(27)31(42)38(2)3/h4-11,14-17,34,37H,12-13,33H2,1-3H3,(H,35,41)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.10	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263569 (2-(4-{5-amino-4-[5- (morpholine-4-carbonyl)-1h- in...) Show SMILES CN(C)C(=O)c1ccccc1Oc1ccc(c(Cl)c1)-n1ncc(C(=O)c2cc3cc(ccc3[nH]2)C(=O)N2CCOCC2)c1N Show InChI InChI=1S/C32H29ClN6O5/c1-37(2)32(42)22-5-3-4-6-28(22)44-21-8-10-27(24(33)17-21)39-30(34)23(18-35-39)29(40)26-16-20-15-19(7-9-25(20)36-26)31(41)38-11-13-43-14-12-38/h3-10,15-18,36H,11-14,34H2,1-2H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.30	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263570 (2-(4-{5-amino-4-[5-(4- methylamino-piperidine-1- c...) Show SMILES CNC1CCN(CC1)C(=O)c1ccc2[nH]c(cc2c1)C(=O)c1cnn(c1N)-c1ccc(Oc2ccccc2C(=O)N(C)C)cc1Cl Show InChI InChI=1S/C34H34ClN7O4/c1-37-22-12-14-41(15-13-22)33(44)20-8-10-27-21(16-20)17-28(39-27)31(43)25-19-38-42(32(25)36)29-11-9-23(18-26(29)35)46-30-7-5-4-6-24(30)34(45)40(2)3/h4-11,16-19,22,37,39H,12-15,36H2,1-3H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.10	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM263571 (2-{5-amino-1-[2-chloro-4-(2- dimethylcarbamoyl-phe...) Show SMILES CN(C)C(=O)c1ccccc1Oc1ccc(c(Cl)c1)-n1ncc(C(=O)c2cc3cc(ccc3[nH]2)C(O)=O)c1N Show InChI InChI=1S/C28H22ClN5O5/c1-33(2)27(36)18-5-3-4-6-24(18)39-17-8-10-23(20(29)13-17)34-26(30)19(14-31-34)25(35)22-12-16-11-15(28(37)38)7-9-21(16)32-22/h3-14,32H,30H2,1-2H3,(H,37,38)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.15	n/a
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc...				US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM235155 (US9359345, 1) Show SMILES NC(=O)c1nc(sc1Nc1ccccn1)N1CCC[C@H](C1)NC(=O)N1Cc2ccccc2C1 |r| Show InChI InChI=1S/C23H25N7O2S/c24-20(31)19-21(27-18-9-3-4-10-25-18)33-23(28-19)29-11-5-8-17(14-29)26-22(32)30-12-15-6-1-2-7-16(15)13-30/h1-4,6-7,9-10,17H,5,8,11-14H2,(H2,24,31)(H,25,27)(H,26,32)/t17-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	254	n/a	n/a	n/a	n/a	7.15	14
HOFFMANN-LA ROCHE INC. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9359345 (2016) BindingDB Entry DOI: 10.7270/Q2668C21
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM235156 (US9359345, 2) Show SMILES NC(=O)c1nc(sc1Nc1ccccn1)N1CCC[C@H](C1)NC(=O)N1Cc2ccc(Cl)cc2C1 |r| Show InChI InChI=1S/C23H24ClN7O2S/c24-16-7-6-14-11-31(12-15(14)10-16)22(33)27-17-4-3-9-30(13-17)23-29-19(20(25)32)21(34-23)28-18-5-1-2-8-26-18/h1-2,5-8,10,17H,3-4,9,11-13H2,(H2,25,32)(H,26,28)(H,27,33)/t17-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7.74E+3	n/a	n/a	n/a	n/a	7.15	14
HOFFMANN-LA ROCHE INC. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9359345 (2016) BindingDB Entry DOI: 10.7270/Q2668C21
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM235157 (US9359345, 3) Show SMILES CC(C)(C)OC(=O)N[C@@H]1CCCN(C1)c1nc(C(N)=O)c(Nc2ccccn2)s1 |r| Show InChI InChI=1S/C19H26N6O3S/c1-19(2,3)28-18(27)22-12-7-6-10-25(11-12)17-24-14(15(20)26)16(29-17)23-13-8-4-5-9-21-13/h4-5,8-9,12H,6-7,10-11H2,1-3H3,(H2,20,26)(H,21,23)(H,22,27)/t12-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.21E+3	n/a	n/a	n/a	n/a	7.15	14
HOFFMANN-LA ROCHE INC. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9359345 (2016) BindingDB Entry DOI: 10.7270/Q2668C21
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM235158 (US9359345, 4) Show SMILES CC(C)(C)c1ccc(cn1)C(=O)N[C@@H]1CCCN(C1)c1nc(C(N)=O)c(Nc2ccccn2)s1 |r| Show InChI InChI=1S/C24H29N7O2S/c1-24(2,3)17-10-9-15(13-27-17)21(33)28-16-7-6-12-31(14-16)23-30-19(20(25)32)22(34-23)29-18-8-4-5-11-26-18/h4-5,8-11,13,16H,6-7,12,14H2,1-3H3,(H2,25,32)(H,26,29)(H,28,33)/t16-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.73E+3	n/a	n/a	n/a	n/a	7.15	14
HOFFMANN-LA ROCHE INC. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9359345 (2016) BindingDB Entry DOI: 10.7270/Q2668C21
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM235159 (US9359345, 5) Show SMILES NC(=O)c1nc(sc1Nc1ccccn1)N1CCC[C@H](C1)NC(=O)Cc1ccccc1 |r| Show InChI InChI=1S/C22H24N6O2S/c23-20(30)19-21(26-17-10-4-5-11-24-17)31-22(27-19)28-12-6-9-16(14-28)25-18(29)13-15-7-2-1-3-8-15/h1-5,7-8,10-11,16H,6,9,12-14H2,(H2,23,30)(H,24,26)(H,25,29)/t16-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6.24E+3	n/a	n/a	n/a	n/a	7.15	14
HOFFMANN-LA ROCHE INC. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9359345 (2016) BindingDB Entry DOI: 10.7270/Q2668C21
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM235160 (US9359345, 6) Show SMILES Cc1cccc(CC(=O)N[C@@H]2CCCN(C2)c2nc(C(N)=O)c(Nc3ccccn3)s2)c1 |r| Show InChI InChI=1S/C23H26N6O2S/c1-15-6-4-7-16(12-15)13-19(30)26-17-8-5-11-29(14-17)23-28-20(21(24)31)22(32-23)27-18-9-2-3-10-25-18/h2-4,6-7,9-10,12,17H,5,8,11,13-14H2,1H3,(H2,24,31)(H,25,27)(H,26,30)/t17-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7.51E+3	n/a	n/a	n/a	n/a	7.15	14
HOFFMANN-LA ROCHE INC. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9359345 (2016) BindingDB Entry DOI: 10.7270/Q2668C21
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM235161 (US9359345, 7) Show SMILES CC(C)(C)c1ccc(cc1)C(=O)N[C@@H]1CCCN(C1)c1nc(C(N)=O)c(Nc2ccccn2)s1 |r| Show InChI InChI=1S/C25H30N6O2S/c1-25(2,3)17-11-9-16(10-12-17)22(33)28-18-7-6-14-31(15-18)24-30-20(21(26)32)23(34-24)29-19-8-4-5-13-27-19/h4-5,8-13,18H,6-7,14-15H2,1-3H3,(H2,26,32)(H,27,29)(H,28,33)/t18-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	470	n/a	n/a	n/a	n/a	7.15	14
HOFFMANN-LA ROCHE INC. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9359345 (2016) BindingDB Entry DOI: 10.7270/Q2668C21
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM235162 (US9359345, 8) Show SMILES CS(=O)(=O)N[C@@H]1CCCN(C1)c1nc(C(N)=O)c(Nc2ccccn2)s1 |r| Show InChI InChI=1S/C15H20N6O3S2/c1-26(23,24)20-10-5-4-8-21(9-10)15-19-12(13(16)22)14(25-15)18-11-6-2-3-7-17-11/h2-3,6-7,10,20H,4-5,8-9H2,1H3,(H2,16,22)(H,17,18)/t10-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.07E+3	n/a	n/a	n/a	n/a	7.15	14
HOFFMANN-LA ROCHE INC. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9359345 (2016) BindingDB Entry DOI: 10.7270/Q2668C21
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM235163 (US9359345, 9) Show SMILES NC(=O)c1nc(sc1Nc1ccccn1)N1CCC[C@H](C1)NS(=O)(=O)c1ccccc1 |r| Show InChI InChI=1S/C20H22N6O3S2/c21-18(27)17-19(23-16-10-4-5-11-22-16)30-20(24-17)26-12-6-7-14(13-26)25-31(28,29)15-8-2-1-3-9-15/h1-5,8-11,14,25H,6-7,12-13H2,(H2,21,27)(H,22,23)/t14-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.61E+3	n/a	n/a	n/a	n/a	7.15	14
HOFFMANN-LA ROCHE INC. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9359345 (2016) BindingDB Entry DOI: 10.7270/Q2668C21
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM235164 (US9359345, 10) Show SMILES CC(C)S(=O)(=O)N[C@@H]1CCCN(C1)c1nc(C(N)=O)c(Nc2ccccn2)s1 |r| Show InChI InChI=1S/C17H24N6O3S2/c1-11(2)28(25,26)22-12-6-5-9-23(10-12)17-21-14(15(18)24)16(27-17)20-13-7-3-4-8-19-13/h3-4,7-8,11-12,22H,5-6,9-10H2,1-2H3,(H2,18,24)(H,19,20)/t12-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.80E+3	n/a	n/a	n/a	n/a	7.15	14
HOFFMANN-LA ROCHE INC. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9359345 (2016) BindingDB Entry DOI: 10.7270/Q2668C21
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM235165 (US9359345, 11) Show SMILES NC(=O)c1nc(sc1Nc1ccccn1)N1CCC[C@H](C1)NC(=O)CNc1cccc(Cl)c1 |r| Show InChI InChI=1S/C22H24ClN7O2S/c23-14-5-3-6-15(11-14)26-12-18(31)27-16-7-4-10-30(13-16)22-29-19(20(24)32)21(33-22)28-17-8-1-2-9-25-17/h1-3,5-6,8-9,11,16,26H,4,7,10,12-13H2,(H2,24,32)(H,25,28)(H,27,31)/t16-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.37E+3	n/a	n/a	n/a	n/a	7.15	14
HOFFMANN-LA ROCHE INC. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9359345 (2016) BindingDB Entry DOI: 10.7270/Q2668C21
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM235166 (US9359345, 12) Show SMILES CC(=O)N[C@@H]1CCCN(C1)c1nc(C(N)=O)c(Nc2ccccn2)s1 |r| Show InChI InChI=1S/C16H20N6O2S/c1-10(23)19-11-5-4-8-22(9-11)16-21-13(14(17)24)15(25-16)20-12-6-2-3-7-18-12/h2-3,6-7,11H,4-5,8-9H2,1H3,(H2,17,24)(H,18,20)(H,19,23)/t11-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6.03E+3	n/a	n/a	n/a	n/a	7.15	14
HOFFMANN-LA ROCHE INC. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9359345 (2016) BindingDB Entry DOI: 10.7270/Q2668C21
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250515 (US9469644, 1) Show SMILES CC(C)(C)c1ccc(cc1)C(=O)NC1CCCC(C1)Nc1ncnc2[nH]cnc12 Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	9.57E+3	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Res...				US Patent US9469644 (2016) BindingDB Entry DOI: 10.7270/Q24Q7SXC
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250516 (US9469644, 2) Show SMILES Clc1cccc(CNC(=O)C2CCCC(C2)Nc2ncnc3[nH]cnc23)c1 Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	1.00E+5	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Res...				US Patent US9469644 (2016) BindingDB Entry DOI: 10.7270/Q24Q7SXC
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250517 (US9469644, 3) Show SMILES Cn1cc(Nc2nc(NC3CCCCC3)c3nc[nH]c3n2)cn1 Show InChI InChI=1S/C15H20N8/c1-23-8-11(7-18-23)20-15-21-13-12(16-9-17-13)14(22-15)19-10-5-3-2-4-6-10/h7-10H,2-6H2,1H3,(H3,16,17,19,20,21,22)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.82E+3	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Res...				US Patent US9469644 (2016) BindingDB Entry DOI: 10.7270/Q24Q7SXC
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250518 (US9469644, 4) Show SMILES CC1CCCC(C1)Nc1nc(Nc2cnn(C)c2)nc2[nH]cnc12 Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.06E+4	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Res...				US Patent US9469644 (2016) BindingDB Entry DOI: 10.7270/Q24Q7SXC
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250519 (US9469644, 5) Show SMILES Cn1cc(Nc2nc(NC3CCCC(C3)NC(=O)c3ccc(cc3)C(C)(C)C)c3nc[nH]c3n2)cn1 Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	56.9	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Res...				US Patent US9469644 (2016) BindingDB Entry DOI: 10.7270/Q24Q7SXC
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250520 (US9469644, 6) Show SMILES O=C(NC1CCCC(C1)Nc1ncnc2[nH]cnc12)c1ccccc1 Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	45.3	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Res...				US Patent US9469644 (2016) BindingDB Entry DOI: 10.7270/Q24Q7SXC
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM250521 (US9469644, 7) Show SMILES CC(C)(C)OC(=O)NC1CCCC(C1)C(O)=O Show InChI InChI=1S/C12H21NO4/c1-12(2,3)17-11(16)13-9-6-4-5-8(7-9)10(14)15/h8-9H,4-7H2,1-3H3,(H,13,16)(H,14,15)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	US Patent	n/a	n/a	109	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (FOrster/Flouresence Res...				US Patent US9469644 (2016) BindingDB Entry DOI: 10.7270/Q24Q7SXC
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM249203 (US9458105, I-1) Show SMILES CC(C)(C)c1cc(F)c2c(cnn(Cc3ccc(cc3)-c3cc[nH]c(=O)c3)c2=O)c1 Show InChI InChI=1S/C24H22FN3O2/c1-24(2,3)19-10-18-13-27-28(23(30)22(18)20(25)12-19)14-15-4-6-16(7-5-15)17-8-9-26-21(29)11-17/h4-13H,14H2,1-3H3,(H,26,29)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.32E+3	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9458105 (2016) BindingDB Entry DOI: 10.7270/Q2QN65P0
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM249204 (US9458105, I-2) Show SMILES CC(C)(C)c1cc(F)c2c(cnn(Cc3ccc(cc3F)-c3cc[nH]c(=O)c3)c2=O)c1 Show InChI InChI=1S/C24H21F2N3O2/c1-24(2,3)18-8-17-12-28-29(23(31)22(17)20(26)11-18)13-16-5-4-14(9-19(16)25)15-6-7-27-21(30)10-15/h4-12H,13H2,1-3H3,(H,27,30)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	983	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9458105 (2016) BindingDB Entry DOI: 10.7270/Q2QN65P0
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM249205 (US9458105, I-3) Show SMILES CC(C)(C)c1cc(F)c2c(cnn(-c3cccc(-c4cc[nH]c(=O)c4)c3CO)c2=O)c1 Show InChI InChI=1S/C24H22FN3O3/c1-24(2,3)16-9-15-12-27-28(23(31)22(15)19(25)11-16)20-6-4-5-17(18(20)13-29)14-7-8-26-21(30)10-14/h4-12,29H,13H2,1-3H3,(H,26,30)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	366	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9458105 (2016) BindingDB Entry DOI: 10.7270/Q2QN65P0
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM249206 (US9458105, I-4) Show SMILES CC(C)(C)c1cc(F)c2c(cnn(Cc3c(F)cc(cc3F)-c3cc[nH]c(=O)c3)c2=O)c1 Show InChI InChI=1S/C24H20F3N3O2/c1-24(2,3)16-6-15-11-29-30(23(32)22(15)20(27)10-16)12-17-18(25)7-14(8-19(17)26)13-4-5-28-21(31)9-13/h4-11H,12H2,1-3H3,(H,28,31)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.33E+4	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9458105 (2016) BindingDB Entry DOI: 10.7270/Q2QN65P0
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM249207 (US9458105, I-5) Show SMILES CC(C)(C)c1cc(F)c2c(cnn(Cc3ccc(cc3CO)-c3cc[nH]c(=O)c3)c2=O)c1 Show InChI InChI=1S/C25H24FN3O3/c1-25(2,3)20-9-18-12-28-29(24(32)23(18)21(26)11-20)13-17-5-4-15(8-19(17)14-30)16-6-7-27-22(31)10-16/h4-12,30H,13-14H2,1-3H3,(H,27,31)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.14E+3	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9458105 (2016) BindingDB Entry DOI: 10.7270/Q2QN65P0
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM249208 (US9458105, I-6) Show SMILES Cn1cc(cn1)-c1cc(cc(=O)[nH]1)-c1ccc(Cn2ncc3cc(cc(F)c3c2=O)C(C)(C)C)c(F)c1 Show InChI InChI=1S/C28H25F2N5O2/c1-28(2,3)21-7-19-12-32-35(27(37)26(19)23(30)11-21)15-17-6-5-16(8-22(17)29)18-9-24(33-25(36)10-18)20-13-31-34(4)14-20/h5-14H,15H2,1-4H3,(H,33,36)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	14.2	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9458105 (2016) BindingDB Entry DOI: 10.7270/Q2QN65P0
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM249209 (US9458105, I-7) Show SMILES Cc1c(NC(=O)c2ccc(cc2)C(C)(C)C)cccc1-c1cc[nH]c(=O)c1 Show InChI InChI=1S/C23H24N2O2/c1-15-19(17-12-13-24-21(26)14-17)6-5-7-20(15)25-22(27)16-8-10-18(11-9-16)23(2,3)4/h5-14H,1-4H3,(H,24,26)(H,25,27)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6.91E+3	n/a	n/a	n/a	n/a	7.15	14
Hoffmann-La Roche Inc. US Patent					Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Forster/Fluorescence Re...				US Patent US9458105 (2016) BindingDB Entry DOI: 10.7270/Q2QN65P0
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 1592 total )  |  Next  |  Last  >>

Jump to: